Redx pleased with progress in busy first half
Date added:
22/06/2015
PHARMACEUTICAL development firm Redx said it was "pleased with progress" as it posted its first half-year figures since listing on AIM. The Liverpool and Alderley Park-based group, which raised £15m in March, increased its interim loss from £2m to £3.3m on revenue of £5.5m (£5.2m in 2014.) RedX is working in three main areas - oncology, immunology and anti-infectives. Chief executive Dr Neil Murray said: "There are no great surprises in these results. We are pleased with the progress we have made since t.....
Back to all news